Bacterial Infections Chapter 14

Bacterial Infections Chapter 14

Bacterial Infections Chapter 14 Infections Caused by Gram Positive Organisms. Michael Hohnadel, D.O. 10/7/03 1 •Staphylococcal Infections • General • 20% of adults are nasal carriers. • HIV infected are more frequent carriers. • Lesions are usually pustules, furuncles or erosions with honey colored crust. • Bullae, erythema, widespread desquamation possible. • Embolic phenomena with endocarditis: • Olser nodes • Janeway Lesions 2 Embolic Phenomena With Endocarditis • Osler nodes Janeway lesion 3 Superficial Pustular Folliculitis • Also known as Impetigo of Bockhart • Presentation: Superficial folliculitis with thin wall, fragile pustules at follicular orifices. – Develops in crops and heal in a few days. – Favored locations: • Extremities and scalp • Face (esp periorally) • Etiology: S. Aureus. 4 Sycosis Vulgaris (Sycosis Barbae) • Perifollicular, Chronic , pustular staph infection of the bearded region. • Presentation: Itch/burn followed by small, perifollicular pustules which rupture. New crops of pustules frequently appear esp after shaving. • Slow spread. • Distinguishing feature is upper lip location and persistence. – Tinea is lower. – Herpes short lived – Pseudofolliculitis Barbea ingrown hair and papules. 5 Sycosis Vulgaris 6 Sycosis Lupoides • Staph infection that through extension results in central hairless scar surrounded by pustules. Pyogenic folliculitis and perifolliculitis with deep extension into hair follicles often with edema. • Thought to resemble lupus vulgaris in appearance. • Etiology: S. Aureus 7 Treatment of Folliculitis • Cleansing with soap and water. • Bactroban (Mupirocin) • Burrows solution for acute inflammation. • Antibiotics: cephalosporin, penicillinase resistant PCN. 8 Furunculosis • Presentation: Perifollicular, round, tender abscess that ends in central suppuration. • Etiology: S. Aureus • Breaks in skin integrity is important. – Various systemic disorders may predispose. • Hospital epidemics of abx resistant staph may occur – Meticulous hand washing is essential. 9 Furuncle 10 Furuncle / Carbuncle 11 Furunculosis • Treatment of acute lesions – ABX may arrest early furuncles. – Incision and drainage AFTER furuncle is localized with definite fluctuation. • No incision of EAC or nasal furuncles. TX with ABX. – Upper lip and nose ,‘danger triangle’, requires prompt treatment with ABX to avoid possible venous sinus thrombosis, septicemia, meningitis. 12 Treatment of Chronic Furunculosis Avoid auto-inoculation, Eliminate carrier state. – Nares, axilla, groin and perianal sites of colonization. – Use Anti-staph cleansers – soap, chlorhexidine. – Frequent laundering – Bactroban to nares of pt and family members • BID to nares for one week (q 4th week.). – Rifampin 600mg QD for 10 days with cloxacillin 500 mg QID (or Clindamycin 150mg qd for 3 mo) 13 Pyogenic Paronychia • Presentation: Tender painful swelling involving the skin surrounding the fingernail. • Etiology: Moisture induced separation of eponychium from nail plate by trauma or moisture leading to secondary infection. – Often work related • Bacteria cause acute abscess formation, Candida causes chronic swelling. • Treatment: • Avoid maceration / trauma • I&D of abscess • PCN, 1st Gen Cephalosporin, augmentin. • Chronic infection requires fungicide and a bactericide. 14 Pyogenic Paronychia • 15 Pyogenic Paronychia 16 Other predominately Staph Infections. • Botrymycosis – Presentation: Chronic, indolent d/o characterized by nodular, crusted, purulent lesions. • Sinus tracts discharge sulfur granules. Scaring. – Uncommon disorder. Altered immune function. – S. Aureus most common. (Pseudo, E-coli, Proteus, Bacteroides, Strep.) • Pyomyositis – S. aureus abcess in deep, large striated muscle. – Most frequent location is thigh – Occurs in tropics and in children as well as AIDS pts. – Not associated with previous laceration. 17 Pyomyositis • 18 Impetigo Contagiosa • Presentation: 2mm erythematous papule develops into vesicles and bullae. Upon rupture a straw colored seropurulent discharge dries to form yellow, friable crust. • Etiology: S. Aureus > S. Pyogenes. • Lesions located on exposed parts of body. • Group A Strep can cause AGN – Children <6 yrs old. – 2% to 5% – Serotytpes 49, 55, 57, 60 strain M2 most associated – Good prognosis in children. 19 Impetigo Contagiosa • Treatment – PCN, 1st Gen. Cephalosporin. – Topical: bacitracin or mupirocin after soaking off crust. • Topical ABX prophylaxis of traumatic injury. – Reduced infection 47 % • Treatment of nares for carriers. 20 Impetigo Contagiosa • 21 Impetigo Contagiosa 22 Impetigo Contagiosa • 23 Bullous Impetigo • Presentation: Large, fragile bullae, suggestive of pemphigus. Rupture leaves a circinate, weepy crusted lesion (impetigo circinata). Collarette of scale present. • Affects newborns at the 4-10th days of life. Adults in warm climates 24 Bullous Impetigo 25 Bullous Impetigo 26 Bullous Impetigo • 27 Staphylococcal Scalded Skin Syndrome. • Presentation: Febrile, rapidly evolving generalized desquamation of the skin seen primarily in neonates and children. – Begins with skin tenderness and erythema of neck groin, axillae with sparing of palm and soles – Blistering occurs just beneath granular layer. – Positive Nikolsky’s sign • Etiology: Exotoxin from S. Aureus infection located at a mucosal surface.. • Differentiate from TENS by location of blister plane high in epidermis. • Treatment as before. Prognosis is good. 28 Staphylococcal Scalded Skin Syndrome • 29 Staphylococcal Scalded Skin Syndrome 30 Toxic Shock Syndrome • Acute, febrile, multisystem disease. – One diagnostic criteria is widespread maculopapular eruption. • Causes: – S. Aureus : cervical mucosa historically in early 1980’s. Also: wounds, catheters, nasal packing. Mortality 12 %. – Group A Strep : necrotizing fasciitis. Mortality 30%. • Diagnosis: CDC – Temp >38.9C, erythematous eruption with desquamation of palms and soles 1-2 wks after onset. Hypotension – AND involvement of three of more other systems • GI, muscular, renal, CNS. – AND Test for RMSF, Leptospirosis and rubeola as well as blood urine and CSF should be negative. 31 Toxic Shock Syndrome • Treatment: – Systemic ABX, – Fluid therapy – Drainage of S. Aureus infected site. 32 Streptococcal Skin Infections 33 Ecthyma • Presentation: Vesicle/pustule which enlarges over several days and becomes thickly crusted. When crust is removed a superficial saucer shaped ulcer remains with elevated edges. – Nearly always on shins or dorsal feet. – Heals in a few weeks with scarring. • Agent: Staph or Strep. • Heal with scaring • Gangrene in predisposed individuals. • Treatment: Clean, topical and systemic ABX. 34 Ecthyma • 35 Scarlet Fever • Presentation: 24 –48 hrs after Strep. Pharyngitis onset. – Cutaneous: • Widespread erythema with 1-2 mm papules. Begins on neck and spreads to trunk then extremities. • Pastia’s lines – accentuation over skin folds with petechia. • Circumoral pallor • Desquamation of palms and soles at appox two wks. – May be only evidence of disease. – Other: strawberry tongue • Causes: erythrogenic exotoxin of group A Strep. • Culture to recover organism or use streptolysin O titer if testing is late. • TX: PCN, E-mycin, Cloxacillin. 36 Scarlet Fever 37 Scarlet Fever 38 Scarlet Fever 39 Scarlet Fever 40 Erysipelas • Presentation: erythematous patch with a distinctive raised, indurated advancing border. Affected skin is very painful and is warm to touch. Freq. associated with fever , HA and leukocytosis >20,000. – Face and Legs are most common sites. – Involves superficial dermal lymphatics • Cause: Group A strep., (Group B in newborns) • Differential: – Contact derm: more itching little pain. – Scarlet fever: widespread punctate erythema – Malar rash of Lupus and Acute tuberculoid Leprosy: Absence of fever pain and leukocytosis. • Treatment: Systemic PCN for 10 days. 41 Erysipelas 42 Erysipelas 43 Erysipelas 44 Cellulitis • Presentation: Local erythema and tenderness which intensifies and spreads. Often associated with a discernable wound. Lymphangitis, fever and streaking may accompany the infection. • Group A strep and S. Aureus are usually causative. • Gangrene and sepsis possible particularly in compromised pt. • Treatment: PCNase – resistant PCN, 1st Gen Ceph. 45 Cellulitis 46 Cellulitis 47 Necrotizing Fasciitis • Presentation: Following surgery or trauma (24 to 48 hours) - erythema, pain and edema which quickly progress to central patches of dusky blue discoloration. Anesthesia of the involved skin is very characteristic. By day 4-5 the involved area becomes gangrenous. • Infection of the fascia. • Many causative agents. Aerobic and anaerobic cultures should be taken. • Treatment: Early debridement. ABX. • 20% mortality in best cases • Poor prognostic factors: Age >50, DM, Atherosclerosis, involvement of trunk, delay of surgery >7 days. 48 More Staph and Strep Infections • Blistering Distal dactylitis – Superficial blisters on volar fat pads – Typical pt is 2-16 yrs old • Perianal Dermatitis – Superficial, perianal, well demarcated rim of erythema which is often confused with a dermatitis. – Typical pt is 1-8 yrs old. • Group B infection – Consider in any neonates. Also seen in adults with DM and peripheral vascular disease. • Staph Iniae – 1997 first reported – Cellulitis of hands assoc with preparation of tilapia fish. 49 Perianal Dermatitis 50 Other Gram Positive Infections. 51 Erysipeloid of Rosenbach. • Presentation: Purple, often polygonal, sharply marginated patches occurring on the hands. The central portion of the lesion may fade

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    81 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us